Important: For your application to be considered, we require completion of the application questions. To begin, please click Apply. Complete the application questions that appear on the next page. To finish, click Submit.
Note: Information on LTBI and use of IGRAs will not be addressed in this training and participants who are interested in these topics are strongly encouraged to also participate in the Focus on LTBI training on October 12, 2026.
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~~ ~~
Note: Seats are limited .
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
Training Dates: Tuesday-Thursday, October 13-15, 2026 [in-person training in Oakland, California]. Virtual participation and streaming is not available.
Training Time: Registration is from 8:00 - 8:30 am. (Start & end times are subject to change)
- Day 1 (Tuesday, October 13) 8:30 am - 4:00 pm
- Day 2 (Wednesday, October 14): 8:30 am - 4:00 pm
- Day 3 (Thursday, October 15): 8:30 am - 4:00 pm
Application Deadline: August 7, 2026 [Notification of your training status in typically provided within 2-5 business days after the deadline]
Cost: There is no fee for this training.
Target Audience: This training is intended as an intensive clinical course for experienced medical providers (physicians, nurses, and other licensed medical care providers) who diagnose and treat active TB disease.
Training Format: In-person training includes lecture, discussion, and case presentations.
Credit: This training is approved for up to 15.50 continuing education hours (see below). Certificates will be available approximately 12 weeks after the training.
Topics covered include (partial list):
- epidemiology of TB
- transmission and pathogenesis
- diagnosis, management, and treatment of TB
- laboratory diagnostics
- diagnostic test cases
- radiology
- drug-resistant TB
- pediatric TB
- legal and ethical issues in TB control
- TB and HIV coinfection
- special situations
Training Objectives (partial list):
By the end of the training, participants will be able to:
- summarize new concepts of TB infection pathophysiology that considers “latency” to more likely represent a spectrum of bacterial activity levels rather than a clear-cut dormant versus active state
- identify key populations at risk for TB infection and TB disease based on current epidemiology data to inform and prioritize those populations for testing and treatment
- recognize the most common pulmonary and systemic signs and symptoms of TB to more effectively diagnose TB disease
- initiate a comprehensive medical evaluation of a case presenting as potential TB to assess for disease
- recognize abnormal versus normal findings on chest radiographs to improve accuracy when reviewing radiographs for purposes of TB diagnosis and management
- explain factors which could lead to increased multidrug-resistant TB and how best to prevent and decrease the possibilities
The Curry International Tuberculosis Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This training is approved for up to 15.50 continuing education hours.
The Curry International Tuberculosis Center designates this educational activity for a maximum of 15.50 AMA PRA Category 1 CreditsTM . Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses, Provider Number CEP 12308. This training is approved for up to 15.50 continuing education hours. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the training, or leave the training early. Therefore, partial credit will not be awarded.
The Curry International Tuberculosis Center is designated as a Tuberculosis Center of Excellence for Training, Education, and Medical Consultation (TB COE) via a funded cooperative agreement with the Centers for Disease Control and Prevention. The Curry International Tuberculosis Center prioritizes learners from the western region of the United States which consists of seventeen jurisdictions: Alaska, Arizona, California (including Los Angeles, San Diego, and San Francisco), Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming, and the U.S. Pacific Island Territories.
(will be provided in confirmation email)
Oakland, CA 00000
United States